350% rally in five years! Multibagger stock jumps after reporting 120% YoY rise in net profit during Q1FY27

Sakar Healthcare surged over 4 percent on the NSE after reporting strong Q1FY27 results, with net profit rising 120 percent YoY to about Rs 10.28 crore from Rs 4.67 crore. Revenue from operations grew 38 percent YoY to Rs 72.97 crore, while EBITDA rose 67 percent YoY to Rs 21.25 crore, with EBITDA margin improving to 29 percent from 24 percent and PAT margin expanding to 14 percent from 9 percent. The stock has delivered multibagger returns of around 354 percent over five years, driven by its oncology, antibiotics, and general formulations business.